LeMaitre Vascular Inc. (LMAT)
| Bid | 78 |
| Market Cap | 1.88B |
| Revenue (ttm) | 219.86M |
| Net Income (ttm) | 44.04M |
| EPS (ttm) | 1.93 |
| PE Ratio (ttm) | 43.29 |
| Forward PE | 46.44 |
| Analyst | Buy |
| Ask | 86 |
| Volume | 115,637 |
| Avg. Volume (20D) | 233,944.9 |
| Open | 82.81 |
| Previous Close | 82.82 |
| Day's Range | 81.78 - 84.50 |
| 52-Week Range | 62.39 - 109.58 |
| Beta | 0.88 |
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vas...
Analyst Forecast
According to 9 analyst ratings, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $100, which is an increase of 19.70% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · seekingalpha.com
Stocks Falling On Earnings - What To Do? February Dividend Income ReportAlimentation Couche-Tard has several growth vectors in place with a clear 5-year plan, including organic growth and growth by acquisition. Starting in March, I will increase my Smith Manoeuvre contrib...
